Myoelectrically Controlled Augmented Reality and Gaming for the Treatment of Phantom Limb Pain

NCT ID: NCT02281539

Last Updated: 2016-05-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the clinical investigation is to reduce phantom limb pain (PLP), painful condition affecting 70% of amputees, so as to improve these patients' quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of the clinical investigation is to reduce phantom limb pain (PLP), a painful condition affecting 70% of amputees, so as to improve these patients' quality of life. Traditionally, mirror box therapy and other tools based on the same concept, have been used to alleviate pain, but their efficacy varies greatly. This project targets amputees for whom other PLP treatments have failed. Various virtual environments, including virtual/augmented reality, are controlled by the patient's phantom limb using muscle (myoelectric) signals from the stump. The patient learns to reactivates areas in the brain related to motor control of the missing limb.

The medical device is non-invasive and based on surface electromyography, a standard and widely used clinical and research tool. The surface electrodes are a standard disposable electrodes widely used in clinics and hospitals for EMG and/or ECG.

* Myoelectric amplifiers (battery operated and isolated from the power grid)
* Data acquisition electronics
* Personal computer
* Standard webcam
* Myoelectric pattern recognition (MPR) software
* Virtual Reality (VR)
* Augmented Reality (AR)
* Computer game

The clinical investigation period consists of 12 sessions per patient including 3 short follow-up assessments. Length of the session: 1.5 hours (the first sessions can take longer time due to learning/familiarization). The centers participating in this study can choose between the following treatment administrations:

* 2 times per week (advised)
* 1 time per week
* Daily (5 times per week)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Phantom Limb Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment using myoelectric signals

Virtual- and augmented reality, are controlled by the patient's phantom limb using muscle (myoelectric) signals from the stump. The patient learns to reactivate areas in the brain related to motor control of the missing limb. The medical device is non-invasive and based on surface electromyography

Group Type EXPERIMENTAL

Neuromotus

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neuromotus

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Amputee patients older than 18 years.
* The patient has signed a written informed consent.
* Patients must have been treated with at least one of the following therapies:

1. Conventional mirror training
2. Transcutaneous electrical stimulation (TENS)
3. Acupuncture
4. Self-hypnosis
5. Drug-based
* The last session of previous therapies (1 and 2) must be at least 1 month before beginning the treatment here proposed.
* In the case of drug-based treatments (5), the patient must report no PLP reduction for at least 1 month under the drug-based treatment and no variations on the medicaments dose. Any pain reduction potentially attributed to the drug-based treatment must be at least 3 months old.
* At least a portion of biceps and triceps muscles must be present.

Exclusion Criteria

* Patient must not have a significant cognitive impairment that prevents them from following instructions.
* Upper limb amputees excluding shoulder disarticulation.
* Obese patient will not be automatically excluded, however, an evaluation in the system is required to analyse if sufficient electromyography signals can be recorded.
* Stump pain over 2 VAS of pain.
* Participating in any other clinical study that could interfere with the result in the ongoing study.
* Condition associated with risk of poor protocol compliance.
* Any other condition or symptoms preventing the patient from entering the study, according to the investigator´s judgement.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sahlgrenska University Hospital

OTHER

Sponsor Role collaborator

Region Örebro County

OTHER

Sponsor Role collaborator

Bräcke diakoni Rehabcenter Sfären

UNKNOWN

Sponsor Role collaborator

University Rehabilitation Institute, Republic of Slovenia

OTHER

Sponsor Role collaborator

Integrum

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rickard Brånemark, MD MSC, PhD

Role: STUDY_CHAIR

Integrum AB

Kerstin Caine-Winterberger, OT

Role: PRINCIPAL_INVESTIGATOR

Rehabilitation Center for Upper Limb Prosthetics, Sahlgrenska University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rehabilitation Center for Upper Limb Prosthetics

Gothenburg, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Ortiz-Catalan M, Sander N, Kristoffersen MB, Hakansson B, Branemark R. Treatment of phantom limb pain (PLP) based on augmented reality and gaming controlled by myoelectric pattern recognition: a case study of a chronic PLP patient. Front Neurosci. 2014 Feb 25;8:24. doi: 10.3389/fnins.2014.00024. eCollection 2014.

Reference Type RESULT
PMID: 24616655 (View on PubMed)

Ortiz-Catalan M, Guethmundsdottir RA, Kristoffersen MB, Zepeda-Echavarria A, Caine-Winterberger K, Kulbacka-Ortiz K, Widehammar C, Eriksson K, Stockselius A, Ragno C, Pihlar Z, Burger H, Hermansson L. Phantom motor execution facilitated by machine learning and augmented reality as treatment for phantom limb pain: a single group, clinical trial in patients with chronic intractable phantom limb pain. Lancet. 2016 Dec 10;388(10062):2885-2894. doi: 10.1016/S0140-6736(16)31598-7. Epub 2016 Dec 2.

Reference Type DERIVED
PMID: 27916234 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PLP-004664

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Acupuncture for Phantom Limb Pain
NCT00460161 SUSPENDED PHASE3
Kinematics of Ewing Amputees
NCT06371209 ENROLLING_BY_INVITATION